T1	intervention 61 72	armodafinil
T2	condition 77 108	brain radiation-induced fatigue
T3	eligibility 634 665	participants receiving brain RT
T4	duration 786 830	From September 20, 2010, to October 20, 2012
T5	No-of-participants 832 834	54
T6	outcome 924 944	grade 4-5 toxicities
T7	outcome 954 987	incidence of grade 2-3 toxicities
T8	outcome 1066 1072	nausea
T9	outcome 1080 1089	headaches
T10	outcome 1101 1109	insomnia
T11	outcome 1172 1196	end-RT or 4 week post-RT
T12	outcome 1621 1635	well tolerated
T13	outcome 1720 1760	no overall significant effect on fatigue
